docetaxel anhydrous has been researched along with annonacin in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (annonacin) | Trials (annonacin) | Recent Studies (post-2010) (annonacin) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 38 | 0 | 17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asemota, H; Barker, J; Delgoda, R; Erhabor, J; Foster, K; Kendal-Smith, A; Langat, MK; Matsabisa, M; Oyenihi, O; Rademan, S | 1 |
1 other study(ies) available for docetaxel anhydrous and annonacin
| Article | Year |
|---|---|
Selective cytotoxic and anti-metastatic activity in DU-145 prostate cancer cells induced by Annona muricata L. bark extract and phytochemical, annonacin.
Topics: Annona; Antineoplastic Agents; Carcinoma; Caspases; Cell Line, Tumor; Cell Movement; Docetaxel; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Furans; Humans; Lactones; Male; Membrane Potential, Mitochondrial; Phytotherapy; Plant Bark; Plant Extracts; Plant Leaves; Prostatic Neoplasms; Reactive Oxygen Species | 2020 |